About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,344 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,344 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2341-2360 of 3,344 trials

TerminatedLow Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancerwill scientifically evaluate whether Low Dose Naltrexone (LDN) has activity in refractory solid tumors within the context of a phase II clinical studyNCT01650350·Providence, Rhode Island UnknownAutologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesThis is a single arm, open-label, uni-center, phase I-II study to evaluate the safety and effectiveness of CAR-T/TCR-T cell immunotherapy in treating with different malignancies…NCT03638206·Zhengzhou, Henan RecruitingA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsNCT07115043·Grand Rapids, Michigan and 12 others CompletedThe Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant TumorsHere's a polished version of the text: "This project involves patients with high-expression LRRC15 malignant tumors who are either clinically suspected of or diagnosed with…NCT07651020·Wuhan, Hubei

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

CompletedAnti-CD20 (Cluster of Differentiation Antigen 20) Therapy to Treat Metastatic MelanomaThe purpose of this study is to assess the overall disease control rate of Ofatumumab wo/w Dacarbazine in subjects with American Joint Committee on Cancer (AJCC 2009) unresectable…NCT01376713·Vienna and 1 other

CompletedStudy of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV MelanomaThe purpose of this clinical research study is to compare the best overall response rate (BORR)(as per modified WHO criteria) in patients with previously treated…NCT00289640·Tucson, Arizona and 61 others

CompletedRadiotherapy & Combi in Metastatic MelanomaThe purpose of this study is to investigate the side effects and safety, and effectiveness of combining dabrafenib and trametinib with radiotherapy.NCT02392871·Darlinghurst, New South Wales and 2 others

CompletedLC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From MelanomaThe purpose of this study is to determine if LC beads loaded with Doxorubicin are a safe and effective treatment for melanoma that has spread to the liver.NCT01010984·Louisville, Kentucky and 2 others

CompletedIntratumoral Administration of L19IL2/L19TNFThis Phase II study is an uncontrolled, multicenter, prospective study for patients with malignant melanoma of the skin in clinical stage III or stage IV M1a.NCT02076633·Milan and 1 other

TerminatedA Study to Evaluate the Safety and Efficacy of MGD013 in Patients With MelanomaThis is an open-label, multi-cohort, multi-center Phase I clinical trial to evaluate the efficacy and safety of MGD013 in ① Cohort 1: patients with unresectable, recurrent or…NCT04653038·Beijing, Beijing Municipality and 12 others

TerminatedMAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous MelanomaThis study is being done to evaluate the safety and the clinical activity of MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in patients with unresectable and progressive…NCT00706238·CABA, Buenos Aires and 5 others

UnknownOf 18F MEL050 Using PET/CT in Metastatic MelanomaThe purpose of this study is to investigate the safety and potential effectiveness of the imaging compound 18F MEL050 for finding sites of melanoma.NCT01620749·East Melbourne, Victoria

WithdrawnIntermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 MutationsThis phase II trial studies intermittent dosing of BRAF inhibitor LGX818 (encorafenib) and MEK inhibitor MEK 162 (binimetinib) in treating patients with melanoma that has spread…NCT02263898·Los Angeles, California

TerminatedMeasurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) OximetryThis protocol will take measurements of a variety of tumors involving the skin in order to assess changes in tumor oxygen from hyperoxygenation therapy and standard…NCT03716193·Morgantown, West Virginia

RecruitingComparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant MelanomaThis is a multicenter, two-arm, open-label, randomized controlled phase III clinical trial to evaluate the efficacy and safety of tunlametinib capsule in comparison with the…NCT06008106·Beijing, Beijing Municipality

TerminatedA Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaThe purpose of this phase 2 study is to evaluate the efficacy and safety of NIR178 in combination with PDR001 in multiple solid tumors and diffuse large B-cell lymphoma (DLBCL)…NCT03207867·Santa Monica, California and 20 others

CompletedPhase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic MelanomaThe goal of this clinical research study is to learn if the combination of ipilimumab and ABI-007 (abraxane) can help to control metastatic melanoma.NCT01827111·Houston, Texas

RecruitingA Study of GC101 TIL in Advanced Melanoma98 participants will be randomly assigned 1:1 to the experimental group and the control group for the Phase II clinical trial，this trail is expected to be finished in 24 monthsNCT06703398·Beijing

CompletedStudy to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored StudyThe purpose of this study was to allow continued use of nilotinib in patients who were on nilotinib treatment in a Novartis-sponsored, Oncology Clinical Development \& Medical…NCT01735955·Albany, New York and 32 others

CompletedA Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete ResectionThe purpose of this study is to compare the drug levels, immunogenicity and safety of Nivolumab Process D to Nivolumab Process C after complete resection of stage IIIa/b/c/d or…NCT03980314·Hartford, Connecticut and 36 others

PreviousPage 118 of 168Next